38°42′21″N 9°08′35″W / 38.70572°N 9.14307°W
 Current logo | |
 Former flag (until 2024) | |
| Agency overview | |
|---|---|
| Formed | 1993 |
| Jurisdiction | European Union |
| Headquarters | Lisbon, Portugal |
| Annual budget | €15.2 million (proposed) (2014) [1] |
| Agency executives | |
| Website | euda.europa.eu |
The European Union Drugs Agency (EUDA), known until 2024 as the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), is an agency of the European Union headquartered in Lisbon, Portugal, and established in 1993.
In June 2022,[4] the Council of the European Union approved a reform of the organization which lead to an extension of its mandate.[5]
The EUDA strives to be the "reference point" on drug usage for the European Union's member states, and to deliver "factual, objective, reliable and comparable information" about drug usage, drug addiction and related health complications, including hepatitis, HIV/AIDS and tuberculosis.[6][7] Though the EUDA primarily serves Europe, it also works with other partners, scientists and policy-makers around the world.[6]
- ^ "EMCDDA draft budget for 2014" (PDF). EMCDDA. 6 December 2013. Archived from the original (PDF) on 23 April 2014. Retrieved 17 February 2015.
- ^ Directorate Archived 2022-01-21 at the Wayback Machine EMCDDA.
- ^ EMCDDA Management Board
- ^ AgenceEurope (2022-06-09). "EU Council validates tasks of new European Drugs Agency". agenceurope.eu. Europe Daily Bulletin No. 12968. Retrieved 2022-09-01.
- ^ "New European Union Drugs Agency starts work with broader mandate | www.euda.europa.eu". www.euda.europa.eu. Retrieved 2024-07-02.
- ^ a b "Mission". EMCDDA. Retrieved 17 February 2015.
- ^ Joan Colom (19 September 2014). "A policy-maker's perspective on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'". BMC Infect. Dis. 14 (Suppl 6): S11. doi:10.1186/1471-2334-14-S6-S11. PMC 4178530. PMID 25253290.